Table 2.
Median changes of clinical variables from baseline to final follow-up in the three groups.
| Group 1 | Group 2 | Group 3 | p-value* | |
|---|---|---|---|---|
| Penile length (cm), median (IQR) | + 2.0 (1.0, 2.0) | + 1.0 (1.0, 1.0) | − 2.0 (− 3.0, − 1.0) | < 0.01 |
| IIEF-EF, median (IQR) | + 2.0 (1.0, 2.0) | + 2.5 (1.0, 4.0) | + 2.5 (1.0, 4.5) | 0.73 |
| PDQ-PS, median (IQR) | − 3.0 (− 3.0, 2.0) | − 2.0 (− 3.0, − 1.0) | − 2.0 (− 2.5, − 1.0) | 0.04 |
| PDQ-PP, median (IQR) | − 2.0 (− 2.0, 0.0) | − 0.5 (− 2.0, 0.0) | − 0.5 (− 2.0, 0.0) | 0.21 |
| PDQ-BD, median (IQR) | − 3.0 (− 6.0, − 3.0) | − 3.0 (− 9.0, − 2.0) | − 3.5 (− 8.0, − 4.5) | 0.35 |
| FSFI, median (IQR) | 4.0 (3.0, 5.0) | + 4.5 (3.0, 5.0) | + 4.0 (2.0, 5.0) | 0.91 |
Group 1 grafting procedure + penile prosthesis implant (PPI), Group 2 grafting procedure only, Group 3 Nesbit procedure, IQR interquartile range, IIEF international index of erectile function, PDQ Peyronie’s disease questionnaire, FSFI female sexual function index.
*Kruskal–Wallis test.